Year: 2022

BEHIND THE EIGHT BALL. "On April 25, 2014, the FDA released its proposed deeming regulation that would treat e-cigarettes as a tobacco product for certain purposes. However, the proposed regulation is subject to change and likely will not be finalized for at least a year. Even after the rule is finalized, implementation of certain provisions may take up to three more years." https://lnkd.in/dr9nXzy View in LinkedIn

UK TOBACCO REGULATORS have had a head start on the U.S., with a 2014 smokeless tobacco device approval, likely a game-changer, and indicator of where the overall market in the West is going. View in LinkedIn

2014 APPROVED INHALED NICOTINE by subsidiary of British American Tobacco, Nicoventures, launches Voke for smoking cessation. A stunning development. Non-combustible "next generation nicotine, without the serious health risks of cigarettes". The first approved inhaled nicotine product. http://www.nicoventures.co.uk/announcing-voke-safer-alternative-smoking-licensed-medicines-and-healthcare-products-regulatory View in LinkedIn

MEDICINAL NICOTINE as a "cleaner nicotine product". While research doubt still exists about the health effects of nicotine, this strategy puts BAT's NRT product Voke in direct competition with pharmaceutical NRTs and moves BAT into pharmaceuticals with clinical trials. http://www.nicoventures.co.uk/facts-research-6 View in LinkedIn

"HARM REDUCTION POLICIES have not to date been widely used in tobacco control, in which policies have to date tended to be centred on promoting complete cessation of all tobacco and nicotine use, with harm reduction limited to the introduction of cigarette filters, and (largely discredited) limits on machine-smoked tar yields." https://lnkd.in/dKqF-WQ View in LinkedIn

NICOVENTURES CLINICAL TRIAL ON INHALED MENTHOL NICOTINE. "A pressurized canister that contains a formulation of pharmaceutical grade (free-base) nicotine formulated with propylene glycol, ethanol, saccharin, menthol, and HFA134a (CFC free) propellant." A randomized, open label crossover study of 18 subjects. Historic. http://ntr.oxfordjournals.org/content/early/2014/11/27/ntr.ntu228.full View in LinkedIn

NICOVENTURES EXPLORING THE HARM REDUCTION MARKET. "In 2012, the company set up a medical education plan called Smoking Harm Reduction Education Programme (SHARE). Events held so far include a Pharmacy Forum in June 2012, a GP Forum in November 2012 and a Stop Smoking Advisor Forum February 2013." (Subsidiary of BAT). http://www.tobaccotactics.org/index.php/Nicoventures View in LinkedIn

BRITISH AMERICAN TOBACCO ON BOTH SIDES OF THE FENCE. "Nicoventures has been promoted as "a stand-alone company" within BAT, providing "a range of alternative products... without the real and serious health risks of smoking" - as such "a natural extension of BAT's approach to tobacco harm reduction". http://www.tobaccotactics.org/index.php/Nicoventures View in LinkedIn

"REDUCED RISK PRODUCTS" and "Next Generation Products" are BAT's names for medical nicotine markets, but do not like the concept of "patients". http://www.tobaccotactics.org/index.php/Nicoventures View in LinkedIn

"BAT and its subsidiaries can play a pivotal role in the innovation of less harmful nicotine products, which are affordable and accessible to adult smokers. Through this public commitment to tobacco harm reduction, the Group makes itself accountable to its consumers and society." And profits, of course. http://www.tobaccotactics.org/index.php/Nicoventures View in LinkedIn